VHCP Management II

Latest statistics and disclosures from VHCP Management II's latest quarterly 13F-HR filing:

Companies in the VHCP Management II portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Avexis 30.74 1.04M 74.31
Biohaven Pharmaceutical Holding 15.15 1.66M NEW 22.79
Ascendis Pharma A S 10.94 986492 +21% 27.76
Edge Therapeutics 7.92 1.93M 10.26
Dbv Technologies 7.56 373617 50.68
Ra Pharmaceuticals 5.76 769771 +6% 18.74
BioCryst Pharmaceuticals (BCRX) 5.50 2.48M -59% 5.56
Argenx Se 5.44 647015 NEW 21.04
Axovant Sciences 2.79 301718 -29% 23.19
Acceleron Pharma 1.90 156880 30.39
Cytomx Therapeutics 1.79 288915 15.50
ARCA biopharma (ABIO) 1.03 1.08M 2.40
Akari Therapeutics 0.78 426297 +15% 4.61
Kalvista Pharmaceuticals 0.65 221651 7.36
Lipocine 0.62 386928 -7% 4.02
Ocera Therapeutics 0.56 1.22M 1.16
Obseva Sa 0.51 150000 NEW 8.55
Adverum Biotechnologies 0.28 280000 2.50
Sierra Oncology 0.06 130798 1.17

Past 13F-HR SEC Filings by VHCP Management II

View All Filings